Search Results 881-890 of 18082 for Tuberculosis

1. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

   Known history of active TB (Bacillus Tuberculosis); Uncontrolled diabetes as defined by fasting serum glucose >1.5 x ULN (NOTE: Optimal glycemic control ...

2. Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology - Mayo Clinic

   The presence of infections, highly communicable diseases (AIDS, active tuberculosis, venereal disease, hepatitis) or metastatic bone disease that may interfere ...

3. A Study To Evaluate Rozanolixizumab To Treat Patients With Generalized Myasthenia Gravis - Mayo Clinic

   Evidence of active or latent tuberculosis (TB) as documented by medical history and examination, if applicable, chest x-rays (posterior anterior and lateral) ...

4. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight - Mayo Clinic

   Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm. Prior history of tuberculosis or positive Purified ...

5. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Known active tuberculosis. Known history of Human Immunodeficiency Virus (HIV), Hepatitis B (HBV) or untreated hepatitis C (HCV) infection. History of ...

6. A study assessing esophageal function and remodeling with dupilumab compared with placebo for 24 weeks followed by 104 weeks open-label in adult participants with EoE - Mayo Clinic

   Tuberculosis testing will be performed on a country-by-country basis, according to local guidelines if required by regulatory authorities or ethics boards ...

7. Delgocitinib (topical application route) - Side effects & dosage - Mayo Clinic

   Tuberculosis, or history of—Use with caution. May make these conditions worse. Liver disease (eg, hepatitis B or C), active or; Serious infections, active ...

8. A Phase I Study of MSB2311 in Advanced Solid Tumors - Mayo Clinic

   History of primary immunodeficiency, stem cell or organ transplant, or previous clinical diagnosis of tuberculosis disease. Clinically significant acute ...

9. The BEACON Study (Breast Cancer Outcomes With NKTR-102) - Mayo Clinic

   Patient received pharmacotherapy for hepatitis B or C, tuberculosis or HIV. Patient with known cirrhosis diagnosed with Child-PUGH Class A or higher liver ...

10. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    - Patients with active tuberculosis (TB) are excluded - Severe infections within 4 weeks prior to randomization, including, but not limited to ...